Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy.
Wang
Andrew Z
AZ
Laboratory of Nanomedicine and Biomaterials, Department of Anesthesia, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.
Bagalkot
Vaishali
V
Vasilliou
Christophoros C
CC
Gu
Frank
F
Alexis
Frank
F
Zhang
Liangfang
L
Shaikh
Mariam
M
Yuet
Kai
K
Cima
Michael J
MJ
Langer
Robert
R
Kantoff
Philip W
PW
Bander
Neil H
NH
Jon
Sangyong
S
Farokhzad
Omid C
OC
D000970:Antineoplastic Agents / Q000138:chemical synthesis* / Q000494:pharmacology; D052157:Aptamers, Nucleotide / Q000737:chemistry* / Q000494:pharmacology; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D016503:Drug Delivery Systems / Q000379:methods; D015195:Drug Design; D004354:Drug Screening Assays, Antitumor; D052203:Ferrosoferric Oxide / Q000737:chemistry* / Q000494:pharmacology; D006801:Humans; D008280:Magnetics; D008297:Male; D053758:Nanoparticles / Q000737:chemistry*; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000188:drug therapy*; D013329:Structure-Activity Relationship
D000970:Antineoplastic Agents; D052157:Aptamers, Nucleotide; D052203:Ferrosoferric Oxide